Adaptive Biotechnologies Corporation
ADPT
$9.29
-$0.22-2.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.16% | 51.48% | 36.24% | 3.32% | 17.66% |
| Total Depreciation and Amortization | -9.26% | -17.51% | -20.34% | -11.50% | -3.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.29% | -66.28% | -18.52% | 16.19% | -19.05% |
| Change in Net Operating Assets | -56.64% | 186.93% | 30.13% | 529.40% | 57.89% |
| Cash from Operations | 25.73% | 53.62% | 42.03% | 26.55% | 35.16% |
| Capital Expenditure | 16.68% | 93.84% | 87.62% | 53.23% | 48.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -41.69% | 392.76% | -80.53% | -81.46% | -30.17% |
| Cash from Investing | -42.54% | 589.71% | -79.77% | -84.25% | -29.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12,288.64% | 45.98% | 135.29% | -97.96% | -93.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12,288.64% | 45.98% | 135.29% | -97.96% | -93.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.03% | 141.27% | -5.89% | -174.80% | 37.81% |